Nicotinic Acetylcholine Receptor Signaling Activates Beige Adipocytes and Mediates Systemic Metabolism
Authors:
- 13 May 2026
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 75 (9) , 1511-1524
Abstract
Optimal function of beige adipocytes is essential for energy balance and metabolic homeostasis. We previously identified that cholinergic receptor nicotinic α2 subunit (CHRNA2) mediates a beige fat selective signaling in mice and humans. Here, we investigate the molecular composition of CHRNA2-containing nicotinic acetylcholine receptors (nAChRs) in beige adipocytes and its impact on whole-body metabolism. Expression levels of cholinergic receptor nicotinic β2 subunit (CHRNB2) and CHRNA2 positively correlate within murine and human beige adipocytes, and both nAChRs are regulated by a spectrum of beige-fat regulators. CHRNB2 is essential for the response to nAChR agonists in beige adipocytes. CHRNB2 partial agonists, a family of drugs clinically used for smoking cessation, activate both murine and human beige adipocytes. Mice deficient in Chrnb2, with both whole-body knockout or adipocyte specific deletion, exhibit compromised adaptive thermogenesis in subcutaneous fat and more aggravated metabolic dysfunction after challenge with high-fat-diet feeding compared with control mice, underscoring the importance of the nAChR signaling in maintaining energy balance. This cholinergic signaling declines in subcutaneous fat with aging. These findings indicate CHRNB2 forms a functional receptor with CHRNA2 in beige adipocytes and highlight their potential as therapeutic targets against metabolic disorders. Article Highlights: Beige-adipocyte activity, mediated by CHRNA2, significantly influences adipose function and systemic metabolism. The CHRNB2 subunit forms a functional receptor with CHRNA2 and is essential for the response to nicotinic acetylcholine receptor agonists in beige adipocytes. Deletion of Chrnb2 in mice compromises the adaptive response to cold in subcutaneous adipose tissue and renders exacerbated metabolic dysfunction due to diet-induced obesity. This cholinergic signaling within subcutaneous adipose tissue declines with aging. CHRNB2 partial agonists, a family of drugs clinically used for smoking cessation, activate both murine and human beige adipocytes.Keywords
All Related Versions
Funding Information
- Division of Diabetes, Endocrinology, and Metabolic Diseases (R01DK107583)
- National Institute on Alcohol Abuse and Alcoholism (R01AA028761)
- Howard Hughes Medical Institute
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK097441)
This publication has 56 references indexed in Scilit:
- Sensory-neuron-derived CGRPα controls white adipocyte differentiation and tissue plasticityCell Reports, 2025
- Subcutaneous white adipose tissue independently regulates burn-induced hypermetabolism via immune-adipose crosstalkCell Reports, 2023
- Adipose-tissue plasticity in health and diseaseCell, 2022
- CD81 Controls Beige Fat Progenitor Cell Growth and Energy Balance via FAK SignalingCell, 2020
- The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature dataPsychopharmacology, 2018
- Cellular Aging Contributes to Failure of Cold-Induced Beige Adipocyte Formation in Old Mice and HumansCell Metabolism, 2017
- A Creatine-Driven Substrate Cycle Enhances Energy Expenditure and Thermogenesis in Beige FatCell, 2015
- Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor AgonistCell Metabolism, 2015
- Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat SwitchCell, 2014
- What We Talk About When We Talk About FatCell, 2014